scholarly journals Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin

2002 ◽  
Vol 25 (6) ◽  
pp. 695-704 ◽  
Author(s):  
Ulrich Kragh-Hansen ◽  
Victor Tuan Giam Chuang ◽  
Masaki Otagiri
2008 ◽  
Vol 112 (16) ◽  
pp. 4884-4891 ◽  
Author(s):  
Sudarson Sekhar Sinha ◽  
Rajib Kumar Mitra ◽  
Samir Kumar Pal

1987 ◽  
Vol 15 (2) ◽  
pp. 267-268 ◽  
Author(s):  
GERALDINE FITZPATRICK ◽  
P. FINBARR DUGGAN

2020 ◽  
Vol 27 (30) ◽  
pp. 4907-4931 ◽  
Author(s):  
Loris Leboffe ◽  
Alessandra di Masi ◽  
Fabio Polticelli ◽  
Viviana Trezza ◽  
Paolo Ascenzi

Background: Human serum albumin (HSA), the most abundant protein in plasma, is a monomeric multi-domain macromolecule with at least nine binding sites for endogenous and exogenous ligands. HSA displays an extraordinary ligand binding capacity as a depot and carrier for many compounds including most acidic drugs. Consequently, HSA has the potential to influence the pharmacokinetics and pharmacodynamics of drugs. Objective: In this review, the structural determinants of drug binding to the multiple sites of HSA are analyzed and discussed in detail. Moreover, insight into the allosteric and competitive mechanisms underpinning drug recognition, delivery, and efficacy are analyzed and discussed. Conclusion: As several factors can modulate drug binding to HSA (e.g., concurrent administration of drugs competing for the same binding site, ligand binding to allosteric-coupled clefts, genetic inherited diseases, and post-translational modifications), ligand binding to HSA is relevant not only under physiological conditions, but also in the pharmacological therapy management.


PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e87919 ◽  
Author(s):  
Hiroki Sato ◽  
Victor Tuan Giam Chuang ◽  
Keishi Yamasaki ◽  
Noriyuki Yamaotsu ◽  
Hiroshi Watanabe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document